Biochemical Journal

Research article

Mutational analysis of the two zinc-binding sites of the Bacillus cereus 569/H/9 metallo-β-lactamase

Dominique de SENY, Christelle PROSPERI-MEYS, Carine BEBRONE, Gian Maria ROSSOLINI, Michael I. PAGE, Philippe NOEL, Jean-Marie FRÈRE, Moreno GALLENI


The metallo-β-lactamase BcII from Bacillus cereus 569/H/9 possesses a binuclear zinc centre. The mono-zinc form of the enzyme displays an appreciably high activity, although full efficiency is observed for the di-zinc enzyme. In an attempt to assign the involvement of the different zinc ligands in the catalytic properties of BcII, individual substitutions of selected amino acids were generated. With the exception of His116→Ser (H116S), C221A and C221S, the mono- and di-zinc forms of all the other mutants were poorly active. The activity of H116S decreases by a factor of 10 when compared with the wild type. The catalytic efficiency of C221A and C221S was zinc-dependent. The mono-zinc forms of these mutants exhibited a low activity, whereas the catalytic efficiency of their respective di-zinc forms was comparable with that of the wild type. Surprisingly, the zinc contents of the mutants and the wild-type BcII were similar. These data suggest that the affinity of the β-lactamase for the metal was not affected by the substitution of the ligand. The pH-dependence of the H196S catalytic efficiency indicates that the zinc ions participate in the hydrolysis of the β-lactam ring by acting as a Lewis acid. The zinc ions activate the catalytic water molecule, but also polarize the carbonyl bond of the β-lactam ring and stabilize the development of a negative charge on the carbonyl oxygen of the tetrahedral reaction intermediate. Our studies also demonstrate that Asn233 is not directly involved in the interaction with the substrates.

  • bacterial resistance
  • dinuclear zinc enzymes
  • β-lactamase family


  • Abbreviations used: AAS, atomic absorption; Capso, 3-[cyclohexylamino]-2-hydroxy-1-propanesulphonic acid; dNTPs, deoxynucleoside triphosphates; H116S, a mutant bearing a substitution of His116 with serine, etc.; IMP-1, imipenemase-1; IPTG, isopropyl β-d-thiogalactoside; LB, Luria—Bertani.